Candidal sepsis
ICD-10 B37.7 is a billable code used to indicate a diagnosis of candidal sepsis.
Candidal sepsis is a severe systemic infection caused by Candida species, primarily Candida albicans, which can lead to significant morbidity and mortality, particularly in immunocompromised patients. This condition arises when Candida enters the bloodstream, often following invasive procedures, prolonged antibiotic use, or in the presence of central venous catheters. Patients at higher risk include those with weakened immune systems due to conditions such as HIV/AIDS, cancer, diabetes, or those undergoing immunosuppressive therapy. Symptoms may include fever, chills, tachycardia, and hypotension, which can progress to septic shock if not promptly treated. Diagnosis typically involves blood cultures, and treatment usually consists of antifungal agents such as fluconazole or echinocandins. Early recognition and intervention are critical to improving outcomes in affected patients.
Detailed clinical notes on the patient's immunocompromised status, laboratory results, and treatment plans.
Patients presenting with fever and chills after chemotherapy or prolonged antibiotic therapy.
Ensure that the documentation reflects the systemic nature of the infection and any underlying conditions.
Comprehensive notes on vital signs, treatment interventions, and response to therapy.
Patients in the ICU with septic shock attributed to candidal sepsis.
Accurate documentation of sepsis criteria and treatment protocols is essential for coding.
Used when confirming the presence of Candida in blood samples.
Document the reason for testing and results.
Infectious disease specialists should ensure accurate coding based on test results.
The primary treatment for candidal sepsis includes antifungal medications such as fluconazole or echinocandins, depending on the severity of the infection and the patient's clinical status.
